Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000442246 | SCV000514475 | benign | not specified | 2015-06-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000457334 | SCV000557610 | likely benign | Progressive myoclonic epilepsy | 2023-12-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318392 | SCV000851630 | likely benign | Inborn genetic diseases | 2017-04-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002502482 | SCV002806636 | likely benign | Action myoclonus-renal failure syndrome | 2021-09-15 | criteria provided, single submitter | clinical testing |